Presentation Theater:
Managing Dyslipidemia in Your Patients Livalo's Emerging Clinical Considerations (Not Official IDWeek Programming Sponsored by Kowa Pharmaceuticals See Affiliated Event Guide for More Information)
Saturday, October 5, 2013: 6:00 AM-7:00 AM
Room: The Moscone Center: 300

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2013 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.

Exhibitor Presentation Theater Summary:
This program will provide a 40-minute presentation followed by a 20-minute question and answer session. Meet with Dr. Carl Fichtenbaum, a renowned HIV specialist and clinical trialist, to discuss managing dyslipidemia in your patients. The efficacy, metabolism, and safety profile of LIVALO® (pitavastatin) will be reviewed as well as emerging clinical considerations.

Carl J. Fichtenbaum, MD
Professor of Clinical Medicine
Principal Investigator of the AIDS Clinical Trials Unit
Associate Chairman for Translational Research, Department of Internal Medicine
Board Member, Intrepid Safety Monitoring
University of Cincinnati
Cincinnati, Ohio

Program Objectives:

  • review dyslipidemia management strategies in the context of current guidelines
  • discuss the emerging clinical considerations for LIVALO, including a study in HIV patients
  • review the clinical efficacy, metabolism, and safety profile of LIVALO.

Target Audience: infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Presentation Theater

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.